Interleukin-10 is an essential modulator of mucoid metaplasia in a mouse otitis media model

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 8, 2008, Pages 630-636

  Tsuchiya, Katsuyuki ^a   Komori, Masahiro ^a   Zheng, Qing Yin ^b   Ferrieri, Patricia ^a   Lin, Jizhen ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b JACKSON LABORATORY   (United States)

^c Lions Research Laboratories   (United States)

Author keywords

Interleukin 10 knockout mouse; Mucous cell metaplasia; Pneumococcal middle ear infection

Indexed keywords

INTERLEUKIN 10; MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; GOBLET CELL; HAEMOPHILUS INFLUENZAE; METAPLASIA; MIDDLE EAR; MIDDLE EAR MUCOSA; MOUSE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BACTERIAL INFECTION; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; EAR TUMOR; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; MUCOSA; PATHOLOGY; SPRAGUE DAWLEY RAT; STREPTOCOCCUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; EAR NEOPLASMS; EAR, MIDDLE; GOBLET CELLS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCINS; MUCOUS MEMBRANE; OTITIS MEDIA; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 52449083975     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700814     Document Type: Article

References (31)

1. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
2. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995;13:257-61.
3. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
4. Lee CG, Homer RJ, Cohn L, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 2002;277:35466-74.
5. Makkink MK, Schwerbrock NM, Mähler M, et al. Fate of goblet cells in experimental colitis. Dig Dis Sci 2002;47:2286-97.
6. Schopf LR, Hoffmann KF, Cheever AW, Urban JF Jr, Wynn TA. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J Immunol 2002;168:2383-92.
7. Groux H, O'Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
8. Borish L. IL-10: evolving concepts. J Allergy Clin Immunol 1998;101:293-7.
9. Silvestre JS, Mallat Z, Duriez M, et al. Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2000;87:448-52.
10. De Beaux AC, Maingay JP, Ross JA, Fearon KC, Carter DC. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J Interferon Cytokine Res 1995;15:441-5.
11. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
12. Chmiel JF, Konstan MW, Knesebeck JE, et al. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am J Respir Crit Care Med 1999;160:2040-7.
13. Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol 2000;257:323-6.
14. Hebda PA, Alper CM, Doyle WJ, Burckart GJ, Diven WF, Zeevi A. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol 1998;107:501-7.
15. Melhus A, Ryan AF. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect Immun 2000;68:4024-31.
16. Yellon R, Marucha LP, Carpenter R, Kreutzer D. Cytokines and chronic otitis media with effusion. In: Sade J, ed. Conference on the eustachian tube and middle ear disease Oct 26-29, 1989. Amsterdam, the Netherlands: Kugler Publishers, 1989.
17. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991;101:165-9.
18. Tsuboi Y, Kim Y, Giebink GS, et al. Induction of mucous cell metaplasia in middle ear of rats using a three-step method: an improved model for otitis media with mucoid effusion. Acta Otolaryngol 2002;122:153-60.
19. Kawano H, Haruta A, Tsuboi Y, et al. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol 2002;111:415-22.
20. Melhus A, Ryan AF. A mouse model for acute otitis media. APMIS 2003;111:989-94.
21. Lin J, Vambutas A, Haruta A, Paparella MM, Giebink GS, Kim Y. Pneumococcus activation of the 5-lipoxygenase pathway and production of glycoproteins in the middle ear of rats. J Infect Dis 1999;179:1145-51.
22. Tsuchiya K, Toyama K, Tsuprun V, et al. Pneumococcal peptidoglycan- polysaccharides induce the expression of interleukin-8 in airway epithelial cells by way of nuclear factor-kappaB, nuclear factor interleukin-6, or activation protein-1 dependent mechanisms. Laryngoscope 2007;117:86-91.
23. Lin J, Tsuboi Y, Rimell F, et al. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol 2003:4:384-93.
24. Lin J, Haruta A, Kawano H, et al. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-α: potential cause for mucoid otitis media. J Infect Dis 2000;182:882-7.
25. Ueno K, Lim DJ. Heterogeneity of glycoconjugates in the secretory cells of the chinchilla middle ear and eustachian tubal epithelia: a lectin-gold cytochemical study. J Histochem Cytochem 1991;39:71-80.
26. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and grampositive bacterial cell wall components. Immunity 1999;11:443-51.
27. Wooten RM, Weis JJ. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol 2001;4:274-9.
28. Wooten RM, Ma Y, Yoder RA, et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002;168:348-55.
29. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
30. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD. Upregulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 1995;7:517-23.
31. Benkhart EM, Siedlar M, Wedel A, Werner T, Ziegler-Heitbrock HW. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 2000;165:1612-7.